Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

    NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 19, 2027 (Application) | June 21, 2027 (Application) | October 20, 2027 (Application) | February 22, 2028 (Application) | June 20, 2028 (Application) | October 20, 2028 (Application) | February 20, 2029 (Final application)

    Funding Amounts: $11 million estimated for 3 awards in FY 2027; project duration up to 5 years

    Summary: Supports optimization and development of non-addictive small molecule and biologic pain therapeutics toward IND submission and Phase I testing.

    Key Information: Applicants need an existing therapeutic lead, strong biological rationale, and established assays—not an initial hit-screening project.


    Description

    The NIH HEAL Initiative, through NINDS and participating NIH institutes and centers, supports preclinical optimization and development of safe, effective, non-addictive pain therapeutics. The program aims to advance promising small molecule and biologic candidates toward readiness for Phase II trials through lead optimization, IND-enabling studies, pharmacodynamic or target-engagement biomarkers, IND preparation and submission, and Phase I testing.

    Awards use a milestone-driven UG3/UH3 cooperative agreement with substantial NIH participation in planning and monitoring. Researchers may conduct development work themselves or collaborate with NIH-funded experts and contract research organizations. Each funded project receives a customized Lead Development Team to coordinate strategy and studies. The program seeks to strengthen academic–industrial partnerships and accelerate alternatives to addictive pain treatments.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.